This news story evaluates the effectiveness of multicancer early detection tests in identifying various cancers.
Review of currently available multicancer early detection tests on the US market.
Discussion of the existing evidence surrounding their utility for cancer detection.
Many MCED tests are available, but their effectiveness for saving lives is uncertain.
Evidence supporting the benefits of these tests remains insufficient.
Abstract
This JAMA Medical News story discusses multicancer early detection (MCED) tests, a handful of which are already on the US market despite a lack of evidence about their utility.